The observation that IL-17B effects were not limited to basal-like breast cancer cell lines suggests that the IL-17B/IL-17RB role in TN/basal-like breast tumors is mainly due to upregulation of this pathway rather than to TN/basal-like-specific mechanisms. This evidence concerns the gene IL17RB and breast carcinoma.